KnipBio completes trial on feed efficacy product
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials. Read more >>
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials. Read more >>
Grapefruit USA, Inc., a fully licensed California based cannabis company, is announcing today that it has commenced production of…
read moreFor Bryan resident Benjamin Murray, life is finally clear – but for the first 26 years of his life…
read moreCorbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced…
read moreA wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will…
read moreAbout 100 iCons scholars and applicants gathered in the Integrative Learning Center of UMass Amherst on Nov 9, 2017…
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced that it will present new research…
read moreeSight, a cutting-edge vision enhancement platform, today announces the launch of its latest innovation, eSight 4. eSight’s wearable assistive…
read moreSelectmen unanimously approved an increase to the gas and liquid fuel to be stored at Nano-C. Read more >>
read moreNorwood-based company, Corbus Pharmaceuticals, donated masks and 200 lunches to the staff at Norwood Hospital to support health care…
read moreCorbus Pharmaceuticals Holdings, Inc. today announced several changes to its management team. Read more >>
read more